Onchocerciasis

Onchocerciasis, also known as river blindness, is a disease caused by infection with the parasitic worm Onchocerca volvulus. Symptoms include severe itching, bumps under the skin, and blindness. It is the second-most common cause of blindness due to infection, after trachoma.The parasite worm is spread by the bites of a black fly of the Simulium type. Usually, many bites are required before infection occurs. These flies live near rivers, hence the common name of the disease. Once inside a person, the worms create larvae that make their way out to the skin, where they can infect the next black fly …

Wikipedia

Publications

WHO: World Health Organization · 29 November 2024 English

12 p

tropicales négligées Onchocerciasis https://www.who.int/health-topics/onchocerciasis#tab=tab_1 Onchocercose


WHO: World Health Organization · 26 November 2024 English

xviii, 54 p.

lower respiratory infections, 5) HIV/AIDS, 6) onchocerciasis, 7) congenital defects, 8) sexually transmitted


WHO: World Health Organization · 25 November 2024 English

ix, 43 p.

life cycle and the blackfly larvae vectors of onchocerciasis can also be targeted in aquatic habitats. The


WHO: World Health Organization · 13 November 2024 English

[‎iv]‎, 18 p.

trypanosomiasis Acoziborole 320 mg ODF Scabies and onchocerciasis L-praziquantel 150 mg ODT Emodepside L-praziquantel


WHO: World Health Organization · 6 November 2024 English

12 p.

schistosomiasis, lymphatic filariasis and onchocerciasis carry a larger disease burden than other NTDs human African trypanosomiasis (HAT), scabies, onchocerciasis and visceral leishmaniasis (VL). KEY MESSAGES schistosomiasis, lymphatic filariasis and onchocerciasis have, in comparison, a larger disease burden human African trypanosomiasis, scabies and onchocerciasis, and visceral leishmaniasis (9). Table 1 below Scabies and onchocerciasis Ivermectin 1 mg or 1.5 mg ODT (to be confirmed) Emodepside (onchocerciasis) Moxidectin


WHO: World Health Organization · 1 November 2024 French

12 p

tropicales négligées Onchocerciasis https://www.who.int/health-topics/onchocerciasis#tab=tab_1 Onchocercose


WHO: World Health Organization · 11 October 2024 English

14 p

Elimination of human onchocerciasis: progress report, 2023–2024 Introduction Onchocerciasis, more commonly adult worms, forming nodules under the skin. Onchocerciasis is most prevalent in sub-Saharan Africa, where responsible for most of the symptoms associated with onchocerciasis. As they move through the skin, they cause OCTOBER 2024 The most devastating consequence of onchocerciasis is, however, on the eyes. When microfilariae eventu- ally blindness. It is estimated that onchocerciasis is the second leading infectious cause of


WHO: World Health Organization · 11 October 2024

14 p

No 41 577 Contents 577 Elimination of human onchocerciasis: progress report, 2023–2024 Sommaire 577 Élimination Elimination of human onchocerciasis: progress report, 2023–2024 Introduction Onchocerciasis, more commonly adult worms, forming nodules under the skin. Onchocerciasis is most prevalent in sub-Saharan Africa, where responsible for most of the symptoms associated with onchocerciasis. As they move through the skin, they cause OCTOBER 2024 The most devastating consequence of onchocerciasis is, however, on the eyes. When microfilariae


WHO: World Health Organization · 6 October 2024 English

xvi, 174 p.

for other diseases such as malaria, HIV/AIDS, onchocerciasis • Inadequacy of the national technical platform


WHO: World Health Organization · 4 October 2024 French

14

opportunity for synergy. Not only STH but also onchocerciasis serology can be added to the TAS platform surveys (iTAS) of lymphatic filariasis and onchocerciasis in Cross River, Taraba and Yobe States, Nigeria surveys (iTAS) of lymphatic filariasis and onchocerciasis in Cross River, Taraba and Yobe States, Nigeria


View more